AF Management Think Forward in AF Management for Device Patients
At BIOTRONIK, we have been consistently prioritizing atrial fibrillation (AF) management in the development of our cardiac rhythm devices. Our mission is to lead the way in AF management for CIED patients, ensuring that every heartbeat is monitored, managed, and maintained with the utmost precision and care. Over time, we have generated extensive clinical evidence on our technologies across various therapy areas.
Our Vision is to create a future where AF is detected early, managed effectively, and monitored continuously, providing patients with the highest quality of life.
Think forward.
-
Preventing AF
How Closed-Loop Stimulation Supports Proactive Heart Care
Atrial Fibrillation (AF) is the most common sustained arrhythmia, affecting millions worldwide, and can lead to stroke, dementia and heart failure. As such, it demands forward-thinking, early action. At BIOTRONIK, we focus on proactive care with innovative cardiac technologies that can help prevent, detect, monitor and treat AF. In line with this mission, our Closed-Loop Stimulation (CLS) technology offers a smarter, more responsive rate adaptation solution to manage heart rhythm disorders, helping prevent AF before it starts. CLS has been proven to reduce the risk of AF and support patients during not only physical but also emotional stress—something traditional DDDR pacemakers fail to do.
Image
-
AF Awareness: Prioritizing Proactive Cardiac Care
This September, for Atrial Fibrillation Awareness Month, we’re spotlighting how early intervention technologies are reshaping cardiac care. Atrial fibrillation (AF) affects millions worldwide and often goes undetected until it causes serious harm. At BIOTRONIK, our focus on forward-thinking, proactive care drives innovation across cardiac technologies, helping physicians prevent, detect, diagnose and manage conditions such as AF and improve the quality of life of their patients.
Image
